CEO, Tessara Therapeutics Pty Ltd
Stories naming Dr Christos Papadimitriou. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Startup Daily TV interviews Tessara Therapeutics' CEO about RealBrain, its 3D brain-tissue models for neurological drug discovery, and a fresh push to raise funds; the Melbourne biotech is also among the latest Tech23 companies.
Tessara Therapeutics closed a $2.7 million oversubscribed Round 1 raise led by a New South Wales syndicate, appointed Phillip Smith to its board, and works with CSIRO and Bio-Link Australia.
Wholesale Investor profile of Tessara Therapeutics, a biotech developing 3D human brain tissue for drug discovery; recounts past grants, an R&D tax incentive, CSIRO partnership, board and revenue projections.